Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7986009 | 0.89 | TDP1 (0.36) | TDP1 | |
| SCHEMBL28880448 | 0.88 | LMNA (0.36) | LMNACYP2C19HIF1AABCB1TDP1 | |
| SCHEMBL8905997 | 0.85 | LMNA (0.38) | LMNACYP2C19HIF1AABCB1TDP1 | |
| SCHEMBL1359798 | 0.84 | LMNA (0.38) | LMNACYP2C19HIF1AABCB1TDP1 | |
| SCHEMBL7986005 | 0.84 | ABCB1 (0.39) | LMNACYP2C19HIF1AABCB1TDP1 | |
| SCHEMBL8377994 | 0.82 | LMNA (0.38) | LMNACYP2C19HIF1AABCB1TDP1 | |
| SCHEMBL28880451 | 0.82 | LMNA (0.43) | LMNACYP2C19HIF1AABCB1 | |
| SCHEMBL9515975 | 0.82 | ABCB1 (0.37) | LMNACYP2C19HIF1AABCB1TDP1 | |
| SCHEMBL8905637 | 0.81 | LMNA (0.54) | LMNACYP2C19HIF1AABCB1 | |
| SCHEMBL8763555 | 0.81 | LMNA (0.42) | LMNACYP2C19HIF1AABCB1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116354842-A | Improved preparation method of iomeprol and application of iomeprol in preparation | 重庆圣华曦药业股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| EP-0598751-A4 | SYNTHESIS OF IOVERSOL USING CHLOROACETYL CHLORIDE. | MALLINCKRODT MEDICAL INC (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0598751-A1 | SYNTHESIS OF IOVERSOL USING CHLOROACETYL CHLORIDE | MALLINCKRODT MEDICAL, INC. (US) | 1994-06-01 | — | — | EP | claimed |
| WO-1993001840-A1 | SYNTHESIS OF IOVERSOL USING CHLOROACETYL CHLORIDE | MALLINCKRODT MEDICAL, INC. (US) | 1993-02-04 | — | — | WO | claimed |
| WO-1991011431-A1 | PROCESS FOR PRODUCTION OF IOVERSOL | MALLINCKRODT, INC. (US) | 1991-08-08 | — | — | WO | claimed |
| CN-116354842-A | Improved preparation method of iomeprol and application of iomeprol in preparation | 重庆圣华曦药业股份有限公司 | 2023-06-30 | — | — | CN | disclosed |
| EP-0839056-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-0886634-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0886634-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0513063-A1 | PROCESS FOR PRODUCTION OF IOVERSOL. | MALLINCKRODT INC (US) | 1992-11-19 | — | — | EP | disclosed |
| WO-1991011431-A1 | PROCESS FOR PRODUCTION OF IOVERSOL | MALLINCKRODT, INC. (US) | 1991-08-08 | — | — | WO | disclosed |